JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M909810199 on March 15, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/20/15557    most recent
M909810199v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saifudeen, Z.
Right arrow Articles by El-Dahr, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saifudeen, Z.
Right arrow Articles by El-Dahr, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 20, 15557-15562, May 19, 2000

The Bradykinin Type 2 Receptor Is a Target for p53-mediated Transcriptional Activation*

Zubaida Saifudeen, Hong Du, Susana Dipp, and Samir S. El-DahrDagger

From the Department of Pediatrics, Section of Pediatric Nephrology, Tulane University School of Medicine, New Orleans, Louisiana 70112

The bradykinin type 2 receptor (BK2) is a developmentally regulated G protein-coupled receptor that mediates diverse actions such as vascular reactivity, salt and water excretion, inflammatory responses, and cell growth. However, little is known regarding regulation of the BK2 gene. We report here that the rat BK2 receptor is transcriptionally regulated by the tumor suppressor protein p53. The 5'-flanking region of the rat BK2 gene contains two p53-like binding sites: a sequence at -70 base pairs (P1 site) that is conserved in the murine and human BK2 genes; and a sequence at -707 (P2) that is not. The P1 and P2 motifs bind specifically to p53, as assessed by gel mobility shift assays. Transient transfection into HeLa cells of a CAT reporter construct driven by 1.2-kilobases of the BK2 gene 5'-flanking region demonstrated that the BK2 promoter is dose dependently activated by co-expression of wild-type p53. Co-expression of a dominant negative mutant p53 suppresses the activation of BK2 by wild-type p53. Promoter truncation localized the p53-responsive element to the region between -38 and -94 base pairs encompassing the p53-binding P1 sequence. Furthermore, p53-mediated activation of the BK2 promoter is augmented by the transcriptional co-activators, CBP/p300. Interestingly, removal of the P2 site by truncation or site-directed deletion amplifies p53-mediated activation of the BK2 promoter. These results demonstrate that the rat BK2 promoter is a target for p53-mediated activation and suggest a new physiological role for p53 in the regulation of G protein-coupled receptor gene expression.


* This work was supported by Grants DK-53595 and DK-56264 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence and reprint requests should be addressed: Tulane University School of Medicine, 1430 Tulane Ave., New Orleans, LA 70112. Tel.: 504-588-5377; Fax: 504-584-1852; E-mail: seldahr@tmcpop.tmc.tulane.edu.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. S. El-Dahr, K. Aboudehen, and S. Dipp
Bradykinin B2 receptor null mice harboring a Ser23-to-Ala substitution in the p53 gene are protected from renal dysgenesis
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1404 - F1413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. S. El-Dahr, K. Aboudehen, and Z. Saifudeen
Transcriptional control of terminal nephron differentiation
Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1273 - F1278.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Shen, L. M. Harrison-Bernard, A. J. Fuller, V. Vanderpool, Z. Saifudeen, and S. S. El-Dahr
The Bradykinin B2 Receptor Gene Is a Target of Angiotensin II Type 1 Receptor Signaling
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1140 - 1149.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Van Bodegom, Z. Saifudeen, S. Dipp, S. Puri, B. S. Magenheimer, J. P. Calvet, and S. S. El-Dahr
The Polycystic Kidney Disease-1 Gene Is a Target for p53-mediated Transcriptional Repression
J. Biol. Chem., October 20, 2006; 281(42): 31234 - 31244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Fan, J. Stefkova, and S. S. El-Dahr
Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway
Am J Physiol Renal Physiol, September 1, 2006; 291(3): F670 - F682.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Saifudeen, V. Diavolitsis, J. Stefkova, S. Dipp, H. Fan, and S. S. El-Dahr
Spatiotemporal Switch from {Delta}Np73 to TAp73 Isoforms during Nephrogenesis: IMPACT ON DIFFERENTIATION GENE EXPRESSION
J. Biol. Chem., June 17, 2005; 280(24): 23094 - 23102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Z. Saifudeen, S. Dipp, H. Fan, and S. S. El-Dahr
Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F899 - F909.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Fan, J. R. Harrell, S. Dipp, Z. Saifudeen, and S. S. El-Dahr
A novel pathological role of p53 in kidney development revealed by gene-environment interactions
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F98 - F107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Tan, F. N. Hutchison, and A. A. Jaffa
Mechanisms of angiotensin II-induced expression of B2 kinin receptors
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H926 - H932.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Marks, Z. Saifudeen, S. Dipp, and S. S. El-Dahr
Two Functionally Divergent p53-responsive Elements in the Rat Bradykinin B2 Receptor Promoter
J. Biol. Chem., September 5, 2003; 278(36): 34158 - 34166.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. A. Baptista, M. C. W. Avellar, R. C. Araujo, J. L. Pesquero, J. P. Schanstra, J. L. Bascands, J. P. Esteve, A. C. M. Paiva, M. Bader, and J. B. Pesquero
Transcriptional Regulation of the Rat Bradykinin B2 Receptor Gene: Identification of a Silencer Element
Mol. Pharmacol., December 1, 2002; 62(6): 1344 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Z. Saifudeen, J. Marks, H. Du, and S. S. El-Dahr
Spatial repression of PCNA by p53 during kidney development
Am J Physiol Renal Physiol, October 1, 2002; 283(4): F727 - F733.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. S. EL-DAHR, L. M. HARRISON-BERNARD, S. DIPP, I. V. YOSIPIV, and S. MELEG-SMITH
Bradykinin B2 null mice are prone to renal dysplasia: gene-environment interactions in kidney development
Physiol Genomics, September 8, 2000; 3(3): 121 - 131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.